BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
Emilia Hadziyannis, Stephanos Hadziyannis. Current practice and contrasting views on discontinuation of nucleos(t)ide analog therapy in chronic hepatitis BExpert Review of Gastroenterology & Hepatology 2020; 14(4): 243 doi: 10.1080/17474124.2020.1738219
Takako Inoue, Yasuhito Tanaka. Novel biomarkers for the management of chronic hepatitis BClinical and Molecular Hepatology 2020; 26(3): 261 doi: 10.3350/cmh.2020.0032
Dheyaa Hussein Mohsin, Muthana Saleh Mashkour, Fataneh Fatemi. Design of aptamer-based sensing platform using gold nanoparticles functionalized reduced graphene oxide for ultrasensitive detection of Hepatitis B virusChemical Papers 2020;  doi: 10.1007/s11696-020-01292-1
Magda Rybicka, Krzysztof Piotr Bielawski. Recent Advances in Understanding, Diagnosing, and Treating Hepatitis B Virus InfectionMicroorganisms 2020; 8(9): 1416 doi: 10.3390/microorganisms8091416
Takako Inoue, Yasuhito Tanaka. The Role of Hepatitis B Core-Related AntigenGenes 2019; 10(5): 357 doi: 10.3390/genes10050357
Guanghua Ma, Bin Lou, Feifei Lv, Dejian Zhao, Hui Chen, Xianfei Ye, Yu Chen. HBcrAg, pg RNA and HBsAg dynamically supervise the seroconversion of HBsAg with anti-viral therapyClinica Chimica Acta 2020; 501: 264 doi: 10.1016/j.cca.2019.10.049
Ian Baudi, Takako Inoue, Yasuhito Tanaka. Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGiInternational Journal of Molecular Sciences 2020; 21(3): 949 doi: 10.3390/ijms21030949